The microglial NLRP3 inflammasome is involved in human SARS-CoV-2 cerebral pathogenicity: A report of three post-mortem cases
Viviana Falcón Cama(Latin American School of Medicine), Giselle Pentón‐Rol(Centro de Ingeniería Genética y Biotecnología), Emilio F. Acosta(Cuban Neuroscience Center), Israel Borrajero(Hermanos Ameijeiras Hospital), Javier Marín‐Prida(University of Havana), Eduardo Pentón‐Arias(Latin American School of Medicine), Nelson Acosta‐Rivero(University of Havana), Ana Victoria Casadesús(Center of Molecular Immunology (Cuba)), Leticia del Rosario-Cruz(Hospital Militar Central), Briandy Fernández-Marrero(Center of Molecular Immunology (Cuba)), Leonardo Oramas Díaz(Centro de Ingeniería Genética y Biotecnología), Gerardo Guillén(Hunan City University), Daina Cremata-García(Centro de Ingeniería Genética y Biotecnología), Beatriz Piniella‐Matamoros(Centro de Ingeniería Genética y Biotecnología), Yorexis González(Cuban Neuroscience Center), Teresita Montero-González(Hospital Militar Central), Angelina Díaz García(Center of Molecular Immunology (Cuba)), Majel Cervantes‐Llanos(Centro de Ingeniería Genética y Biotecnología), Daphne E Sanchez(Cuban Neuroscience Center), Nathalie Gilva-Rodríguez(Centro de Ingeniería Genética y Biotecnología)
Cited by 50
Related Papers
Epidermal growth factor in clinical practice – a review of its biological actions, clinical indications and safety implications
|International Wound Journal|2009|167
A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: Report of a pilot clinical trial
|Annals of Oncology|1998|155
Glucose Toxic Effects on Granulation Tissue Productive Cells: The Diabetics’ Impaired Healing
|BioMed Research International|2012|153
Wound Chronicity, Impaired Immunity and Infection in Diabetic Patients
|MEDICC Review|2021|139
Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review
|Frontiers in Endocrinology|2020|134